Pre-Conference Clinical Data Management Master Class Day: Monday, December 7, 2009

12:30 Registration And Coffee

1:00 Welcome Address And Chairperson’s Opening Remarks

1:10 Utilization Of Clinical Rating Scales In Clinical Trials: Concerns, Considerations, And Continuity

  • Developing a cohesive rating scale model
  • Adapting rating scales to meet the needs of your clinical trial study objectives
  • Evaluating implications of ex-US trials, and discussing licensing/copyright issues
  • Discussing best practices and lessons learned regarding ensuring the right translation throughout the trial from start to finish
  • Understanding why Phase 2 and Phase 3 CNS studies fail at a rate of 25%

Nicholas Greco
Clinical Research Manager - Psychometrics and Assessment, Global Pharmaceutical Research & Development
Abbott Laboratories

1:50 Valuable Clinical Packaging Solutions For Your Clinical Supplies

  • Knowing what to look for from your clinical packaging supplier
  • Choosing a compliant packaging organization who will deliver a customer tailored service to your clinical supply chain
  • Choosing a suited clinical packaging partner to develop an aligned approach
  • Considering package lifecycle, company integrity, cost implications and reliability

Philip Butera
Senior Director, Supply Chain
Pfizer

2:30 Panel Discussion: Accurately Forecasting Clinical Trial Supply Demand Data To Reduce Cost

  • Understanding why demand forecasting is critical for your organization
  • Discussing novel and effective forecasting tools and techniques
  • Identifying best practices in forecasting clinical trials supply requirements

Panelists:

Philip Butera
Senior Director Supply Chain
Pfizer

Valerii Fedorov
Head of Research Statistics Unit
GlaxoSmithKline

3:10 Predictive Patient Recruitment And Supply Modeling To Ensure Successful Completion Of Clinical Trials

  • Uncovering the main sources of uncertainty and appropriate metrics for measuring success
  • Modeling and predicting recruitment at the initial and interim stages
  • Examining adaptive adjustment of recruitment and number of clinical centers at any interim time
  • Evaluating study performance and site productivity
  • Predictive modeling for drug supply

Valerii Fedorov
Head of Research Statistics Unit
GlaxoSmithKline

3:50 Chairpersons Closing Remarks And End Of Master Class